![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Evaluation of Drug-Drug Interaction Potential Between
Sofosbuvir/Velpatasvir and Atorvastatin
|
|
|
Reported by Jules Levin
18th International Workshop on Clinical Pharmacology of Antiviral Therapy, June 14-16, 2017, Chicago, IL
Rebecca Begley, Erik Mogalian, Brian McNabb, Gong Shen, Sherry Lee, John Ling, Anita Mathias
Gilead Sciences, Inc., Foster City, California, USA
![0622171](../images/062217/062217-1/0622171.gif)
![0622172](../images/062217/062217-1/0622172.gif)
![0622173](../images/062217/062217-1/0622173.gif)
![0622174](../images/062217/062217-1/0622174.gif)
![0622175](../images/062217/062217-1/0622175.gif)
![0622176](../images/062217/062217-1/0622176.gif)
![0622177](../images/062217/062217-1/0622177.gif)
![0622178](../images/062217/062217-1/0622178.gif)
![0622179](../images/062217/062217-1/0622179.gif)
![06221710](../images/062217/062217-1/06221710.gif)
References
1. Jacobson IM, et al. N Engl J Med 2013;368:1867-77; 2. Lawitz E, et al. N Engl J Med 2013;368:1878-87; 3. Lawitz E, et al. J Viral Hepat 2015;22:1011-9; 4. Curry M, et al.
N Engl J Med 2015;373:2618-28; 5. Feld J, et al. N Engl J Med 2015;373:2599-607; 6. Foster G, et al. N Engl J Med 2015;373:2608-17; 7. Lennernäs H. Clin Pharmacokinet
2003;42:1141-60; 8. Lipitor [package insert]. New York, NY: Pfizer Inc, 3/2015; 9. Juxtapid [package insert]. Cambridge, MA: Aegerion Pharmaceuticals, Inc., 5/2016;
10. Epclusa [package insert]. Foster City, CA: Gilead Sciences, Inc., 2/2017; 11. Mogalian E, et al. CROI 2016, abstr 100.
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|